Literature DB >> 16734130

IL-13 gene expression in patients with atopic dermatitis: relation to IgE level and to disease severity.

Shereen S Metwally1, Youssef M Mosaad, Elham R Abdel-Samee, Maha A El-Gayyar, Abeer M Abdel-Aziz, Farha A El-Chennawi.   

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease frequently associated with an increased serum IgE level. T helper cells are thought to play an important role in the pathogenesis of AD. It is commonly believed that allergens activate Th2 cells, and it is likely that the cytokines produced by Th2 cells are crucial factors in the induction and maintenance of the disease. IL-13 is one of the cytokines that are produced by Th2 lymphocytes and, like IL-4, it can induce the production of IgE. In order to evaluate its role in the pathogenesis of AD, IL-13 mRNA expression was studied in peripheral blood of patients with different degrees of AD and compared with healthy subjects. Also, we correlated its level of expression with the level of serum IgE and with the severity of the disease. EDTA blood was obtained from 25 patients (divided into three groups ranged from mild to severe AD) and 12 normal subjects as a control group. We examined the blood sample for IL-13 mRNA expression using RNA extraction technique, RT-PCR, PCR amplification using primers specific for IL-13 and beta- actin (as internal control) this is followed by visualization of the expressed bands using gel electrophoresis and DNA marker. Serum IgE level was detected using an ELISA kit. Our results revealed that, IL-13 mRNA is significantly expressed in patients with AD as compared to normal control (P<0.001). IL-13 mRNA shows higher level of expression in severe AD group in comparison with both moderate and mild groups (P = 0.05). Serum levels of IgE showed highly significant increase in patients with AD as compared with the control group (p=0.019), its level is significantly higher in severe AD group versus moderate and mild AD groups (P=0.009 and 0.022, respectively). There is a highly significant positive correlation between serum levels of IgE and the levels of IL-13 mRNA expression in all AD groups (P=0.001). In conclusion, the high level of IL-18 mRNA expression in AD, and its correlation with serum level of IgE and with severity of disease indicates that IL-13 is involved in the pathogenesis of the disease and is an important in vivo IgE inducer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16734130

Source DB:  PubMed          Journal:  Egypt J Immunol


  9 in total

Review 1.  Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?

Authors:  Nicholas K Mollanazar; Peter K Smith; Gil Yosipovitch
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

2.  Analysis of changes in expression of IL-4/IL-13/STAT6 pathway and correlation with the selected clinical parameters in patients with atopic asthma.

Authors:  Adam Antczak; Daria Domańska-Senderowska; Paweł Górski; Dorota Pastuszak-Lewandoska; Agnieszka Nielepkowicz-Goździńska; Karolina Szewczyk; Zofia Kurmanowska; Justyna Kiszałkiewicz; Ewa Brzeziańska-Lasota
Journal:  Int J Immunopathol Pharmacol       Date:  2016-01-18       Impact factor: 3.219

Review 3.  Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis.

Authors:  Julia K Gittler; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2012-08-28       Impact factor: 10.793

4.  Th2 Cytokines and Atopic Dermatitis.

Authors:  Eric B Brandt; Umasundari Sivaprasad
Journal:  J Clin Cell Immunol       Date:  2011-08-10

5.  Coexistence of 2282del4 FLG gene mutation and IL-18 -137G/C gene polymorphism enhances the risk of atopic dermatitis.

Authors:  Magdalena Trzeciak; Jolanta Gleń; Krzysztof Rębała; Tadeusz Bandurski; Monika Sikorska; Roman Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2016-02-29       Impact factor: 1.837

6.  Increase risk of allergic diseases in patients with ankylosing spondylitis: A 10-year follow-up population-based study in Taiwan.

Authors:  Wei-Pin Chang; Chun-Nan Kuo; Li-Na Kuo; Yao-Tung Wang; Wuu-Tsun Perng; Ho-Chang Kuo; James Cheng-Chung Wei
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

7.  Interleukin-13 in Asthma and Other Eosinophilic Disorders.

Authors:  Emma Doran; Fang Cai; Cécile T J Holweg; Kit Wong; Jochen Brumm; Joseph R Arron
Journal:  Front Med (Lausanne)       Date:  2017-09-19

8.  Activated Natural Killer Cells Mediate the Suppressive Effect of Interleukin-4 on Tumor Development via STAT6 Activation in an Atopic Condition Melanoma Model.

Authors:  Dong Ju Son; Yu Yeon Jung; Mi Hee Park; Hye Lim Lee; Min Ji Song; Hwan-Soo Yoo; Dae Youn Hwang; Sang Bae Han; Jin Tae Hong
Journal:  Neoplasia       Date:  2017-06-03       Impact factor: 5.715

9.  Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis.

Authors:  Richard L Gieseck; Thirumalai R Ramalingam; Kevin M Hart; Kevin M Vannella; David A Cantu; Wei-Yu Lu; Sofía Ferreira-González; Stuart J Forbes; Ludovic Vallier; Thomas A Wynn
Journal:  Immunity       Date:  2016-07-12       Impact factor: 31.745

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.